SPY299.08+3.64 1.23%
DIA250.25+5.37 2.19%
IXIC9,340.22+15.63 0.17%

Morgan Stanley Maintains Overweight on Livongo Health, Raises Price Target to $62

Morgan Stanley maintains Livongo Health (NASDAQ:LVGO) with a Overweight and raises the price target from $36 to $62.

Benzinga · 05/07/2020 12:46

Morgan Stanley maintains Livongo Health (NASDAQ:LVGO) with a Overweight and raises the price target from $36 to $62.